Artivion Inc [AORT] stock is trading at $29.70, down -0.24%. Until recently, the best way to gauge how the stock has performed was to look at its short-term value. The AORT shares have gain 2.24% over the last week, with a monthly amount drifted -0.03%, and not seem to be holding up well over a long-time horizon.
From an analyst’s perspective:
Artivion Inc [NYSE: AORT] stock has seen the most recent analyst activity on June 17, 2025, when Canaccord Genuity initiated its Buy rating and assigned the stock a price target of $35. Previously, JMP Securities started tracking the stock with Mkt Outperform rating on October 23, 2024, and set its price target to $33. On September 27, 2022, Lake Street reiterated its Buy rating and revised its price target to $28 on the stock. Lake Street started tracking the stock assigning a Buy rating and suggested a price target of $32 on August 08, 2022. Stifel initiated its recommendation with a Buy and recommended $30 as its price target on March 03, 2022.
Artivion Inc [AORT] stock has fluctuated between $21.97 and $32.33 over the past year. Currently, Wall Street analysts expect the stock to reach $30.6 within the next 12 months. Artivion Inc [NYSE: AORT] shares were valued at $29.70 at the most recent close of the market. An investor can expect a potential return of 3.03% based on the average AORT price forecast.
Analyzing the AORT fundamentals
Artivion Inc [NYSE:AORT] reported sales of 390.08M for the trailing twelve months, which represents a growth of 1.59%. Gross Profit Margin for this corporation currently stands at 0.64% with Operating Profit Margin at 0.04%, Pretax Profit Margin comes in at -0.06%, and Net Profit Margin reading is -0.05%. To continue investigating profitability, this company’s Return on Assets is posted at -0.03, Equity is -0.07 and Total Capital is 0.02. Upon thorough examination of the company’s fundamental financial framework, it becomes apparent that the debt-to-equity ratio stands at 1.23.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 29.46 points at the first support level, and at 29.23 for the second support level. However, for the 1st resistance point, the stock is sitting at 29.97, and for the 2nd resistance point, it is at 30.24.
Ratios To Look Out For
For context, Artivion Inc’s Current Ratio is 4.52. As well, the Quick Ratio is 2.95, while the Cash Ratio is 0.73. Considering the valuation of this stock, the price to sales ratio is 3.25, the price to book ratio is 4.31.
Transactions by insiders
Recent insider trading involved Stanton Marshall S., SVP, Clinical & MD Affair, that happened on Jun 17 ’25 when 15000.0 shares were sold. Officer, MARSHALL STANTON completed a deal on Jun 17 ’25 to buy 15000.0 shares. Meanwhile, SVP, Clinical & MD Affair Stanton Marshall S. sold 26132.0 shares on Jun 13 ’25.
